Phase III randomized trial of induction chemotherapy with gemcitabine and carboplatin followed by elective paclitaxel consolidation versus paclitaxel and carboplatin followed by elective paclitaxel consolidation in patients with primary epithelial ovarian, primary peritoneal cancer or fallopian tube carcinoma.

Trial Profile

Phase III randomized trial of induction chemotherapy with gemcitabine and carboplatin followed by elective paclitaxel consolidation versus paclitaxel and carboplatin followed by elective paclitaxel consolidation in patients with primary epithelial ovarian, primary peritoneal cancer or fallopian tube carcinoma.

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Oct 2011

At a glance

  • Drugs Carboplatin; Gemcitabine; Paclitaxel
  • Indications Fallopian tube cancer; Ovarian cancer; Peritoneal cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Jun 2010 This trial will be featured in the Best of ASCO 2010.
    • 06 Jun 2010 Results were presented at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO).
    • 06 Jun 2010 Primary endpoint 'Progression free survival' has not been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top